Will Moderna Stock Rally After 12% Decline Last Week?

Will Moderna Stock Rally After 12% Decline Last Week?

Share to Linkedin An illustrative image of a hand holding a medical syringe in front of the Moderna logo displayed on ... [+] a screen. On Monday, February 1, 2021, in Dublin, Ireland. (Photo by Artur Widak/NurPhoto via Getty Images) Moderna stock (NASDAQ: MRNA) has declined by about -12% over the last week (five trading days), compared to the S&P 500 which is down by about -1. 2% over the same period. Although there hasn't been too much news relating to the company, Moderna stock has likely been hurt by the broader sell-off in high-growth names and Covid-19 winners. Moreover, the market for Covid-19 vaccines is getting more crowded with shots from Johnson & Johnson (NYSE: JNJ), AstraZeneca (NASDAQ: AZN), and Novavax (NASDAQ: NVAX) winning approval or making progress with clinical trials in multiple countries. So will Moderna stock continue its downward trajectory over the coming weeks and months, or is a rally looking more likely? According to the Trefis Machine Learning Engine, which identifies trends in a company's stock price data for the last two years, Moderna stock has a 68% chance of a rise over the next month after declining by about -12% in the last five trading